NeuroQuest Development Center
NeuroQuest Development Center, Inc.
NeuroQuest Development Center, Inc. is a biotechnology company headquartered in Charleston, South Carolina, focused on creating innovative diagnostic solutions for neurodegenerative diseases, primarily Alzheimer's disease. The company aims to provide more affordable and accessible methods for early detection of Alzheimer's, facilitating timely intervention and improved patient outcomes.
Products & Team
NeuroScreen Assay
The NeuroScreen assay is a blood-based diagnostic test developed by NeuroQuest for the early detection of Alzheimer's disease. It utilizes biomarker technology to identify the presence of Alzheimer's-related indicators in blood samples.
NeuroScreen addresses the need for early Alzheimer's detection by providing a cost-effective and convenient alternative to traditional PET scans, promoting earlier intervention strategies.
The high costs and limited accessibility of existing diagnostic methods like PET scans create significant barriers to timely Alzheimer's diagnosis.